This research is focused on the role of ionic alterations in the development of irreversible cell injury. We make use of vivo and in situ NMR methods on cell suspensions and perfused organs in order to determine the cytosolic concentrations of these ions and to monitor associated metabolic changes to which the NMR technique is sensitive. We have previously demonstrated that increases in cytosolic calcium (Ca-i, sodium (Na-i), magnesium (Mg-i), and hydrogen and a decrease in ATP occur during cell injury. Although a consensus appears to be developing that an increase in Ca-i precedes the onset of irreversible injury, this does not prove that an increase in Ca-i is necessary or responsible for the onset of irreversible cell injury. We therefore undertook studies to determine whether it was possible to manipulate experimental conditions to prevent or delay an increase in Ca-i. The perfused rat heart was studied under conditions of: total ischemia, potassium arrest, magnesium arrest, and pretreatment with 0.9 uM diltiazem to reduce but not abolish contractility. In all conditions tested, the increase in Ca-1 preceded lethal injury, as determined by enzyme release. Thus, we have not been able to dissociate the increase in calcium from irreversible cell injury. Using the NMR sensitive indicator 5FBAPTA to measure Ca-i, we have also demonstrated that amiloride significantly attenuates the increase in Ca-1 observed during ischemia. In addition, since ATP, measured by 31 p NMR, falls with a similar time course in the presence and absence of amiloride, we can therefore dissociate the increase in Ca-i from the decrease in ATP. We observed that the presence of amiloride during ischemia allows better recovery of contractile function during reflow after 20 minutes of ischemia. These data strongly suggest that the rise in Ca-i plays an important role in the contractile dysfunction which occurs after ischemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES010004-11
Application #
3876831
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1990
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Huss, Janice M; Imahashi, Ken-ichi; Dufour, Catherine R et al. (2007) The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab 6:25-37
Delozier, Tracy C; Kissling, Grace E; Coulter, Sherry J et al. (2007) Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35:682-8
Murphy, Elizabeth; Steenbergen, Charles (2007) Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev 12:293-300
Murphy, Elizabeth; Steenbergen, Charles (2007) Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 75:478-86
Murphy, Elizabeth; Steenbergen, Charles (2007) Preconditioning: the mitochondrial connection. Annu Rev Physiol 69:51-67
Nikolic, Ivana; Liu, Dianxin; Bell, Jamie A et al. (2007) Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol 42:769-80
Shiva, Sruti; Huang, Zhi; Grubina, Rozalina et al. (2007) Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 100:654-61
Seubert, John M; Sinal, Christopher J; Graves, Joan et al. (2006) Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 99:442-50
Sun, Junhui; Picht, Eckard; Ginsburg, Kenneth S et al. (2006) Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res 98:403-11
Sun, Junhui; Steenbergen, Charles; Murphy, Elizabeth (2006) S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal 8:1693-705

Showing the most recent 10 out of 44 publications